Tag: Bristol-Myers Squibb Co
This up-and-coming cancer treatment could be a $25 billion market opportunity
Skynesher | E+ | Getty ImagesBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a "mas [...]
J&J, Bristol Myers Squibb lose Medicare drug-price talks challenges
Jonathan Raa | Nurphoto | Getty ImagesA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's legal challe [...]
Bristol Myers Squibb (BMY) earnings Q1 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glan [...]
J&J cell therapy gains edge over Bristol Myers rival
Jonathan Raa | Nurphoto | Getty ImagesThink a friend or colleague should be getting this newsletter? Share this link with them to sign up.Hi folks! Tw [...]
Medicare drug price negotiations: Judge rejects AstraZeneca challenge
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on O [...]
Medicare drug price negotiations: Judge tosses PhRMA lawsuit
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 [...]
Merck, J&J, Bristol Myers Squibb CEOs face Senate drug price hearing
(L-R) Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner, CEO of Bristol Myers Squibb, testify before the Sena [...]
Q4 earnings shaping up to be the best of 2023
Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024.Brendan McDermid | ReutersHere's how big of a surprise corporate profits have [...]
Bristol Myers Squibb (BMY) Q4 earnings report 2023
Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales grow [...]
J&J, Merck and Bristol Myers Squibb in the hot seat
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.Good afternoon! This is Annika Kim Constantino, an [...]
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSEBig pharmaceutical companies such as Bristol Myers Squibb, M [...]
Merck, J&J CEOs agree to testify in Senate hearing on drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, 2024, on issuing subpoenas [...]
Medicare drug price negotiations what’s ahead in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 [...]
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share.Kar [...]
Pfizer 2024 revenue, profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street's expectations, as it sees weak demand for its [...]